Showing results (331-340 of 829) with videos related to

Sort By:
Pageof 83
The Medical Journal of Australia|January 11, 2018
The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on anticoagulation therapy in rural AustraliaJamie W Bellinge, Jarrad J Paul, Liam S Walsh, et al.
Journal of Clinical Lipidology|October 15, 2018
Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisalMichael B Boffa, Saverio Stranges, Neil Klar, et al.
European Journal of Clinical Investigation|October 8, 2008
Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndromeD C Chan, G F Watts, T W K Ng, et al.
The American Journal of Clinical Nutrition|February 26, 2010
Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesityDick C Chan, Minh N Nguyen, Gerald F Watts, et al.
Journal of Clinical Pathology|November 1, 1993
Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatinG F Watts, C Castelluccio, C Rice-Evans, et al.
Obesity Research|April 12, 2003
Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndromeDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Journal of Lipid Research|March 8, 2000
Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesityG F Watts, F M Riches, S E Humphries, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2001
Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?J C Mamo, G F Watts, P H Barrett, et al.
Pageof 83